Literature DB >> 30802283

Fibroblast Growth Factor-21 Controls Dietary Protein Intake in Male Mice.

Karlton R Larson1, Aki T-B Chaffin1, Michael L Goodson1, Yanbin Fang1, Karen K Ryan1.   

Abstract

Whereas carbohydrates and lipids are stored as glycogen and fat, there is no analogous inert storage form of protein. Therefore, continuous adjustments in feeding behavior are needed to match amino acid supply to ongoing physiologic need. Neuroendocrine mechanisms facilitating this behavioral control of protein and amino acid homeostasis remain unclear. The hepatokine fibroblast growth factor-21 (FGF21) is well positioned for such a role, as it is robustly secreted in response to protein and/or amino acid deficit. In this study, we tested the hypothesis that FGF21 feeds back at its receptors in the nervous system to shift macronutrient selection toward protein. In a series of behavioral tests, we isolated the effect of FGF21 to influence consumption of protein, fat, and carbohydrate in male mice. First, we used a three-choice pure macronutrient-diet paradigm. In response to FGF21, mice increased consumption of protein while reducing carbohydrate intake, with no effect on fat intake. Next, to determine whether protein or carbohydrate was the primary-regulated nutrient, we used a sequence of two-choice experiments to isolate the effect of FGF21 on preference for each macronutrient. Sweetness was well controlled by holding sucrose constant across the diets. Under these conditions, FGF21 increased protein intake, and this was offset by reducing the consumption of either carbohydrate or fat. When protein was held constant, FGF21 had no effect on macronutrient intake. Lastly, the effect of FGF21 to increase protein intake required the presence of its co-receptor, β-klotho, in neurons. Taken together, these findings point to a novel liver→nervous system pathway underlying the regulation of dietary protein intake via FGF21.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30802283      PMCID: PMC6469953          DOI: 10.1210/en.2018-01056

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  73 in total

1.  Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.

Authors:  Clarence Hale; Michelle M Chen; Shanaka Stanislaus; Narumol Chinookoswong; Todd Hager; Minghan Wang; Murielle M Véniant; Jing Xu
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

2.  Effect of amino acid imbalance in rats fed ad libitum, interval-fed or force-fed.

Authors:  P M Leung; Q R Rogers; A E Harper
Journal:  J Nutr       Date:  1968-07       Impact factor: 4.798

3.  FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver.

Authors:  Stephanie von Holstein-Rathlou; Lucas D BonDurant; Lila Peltekian; Meghan C Naber; Terry C Yin; Kristin E Claflin; Adriana Ibarra Urizar; Andreas N Madsen; Cecilia Ratner; Birgitte Holst; Kristian Karstoft; Aurelie Vandenbeuch; Catherine B Anderson; Martin D Cassell; Anthony P Thompson; Thomas P Solomon; Kamal Rahmouni; Sue C Kinnamon; Andrew A Pieper; Matthew P Gillum; Matthew J Potthoff
Journal:  Cell Metab       Date:  2015-12-24       Impact factor: 27.287

4.  Rapid Sensing of Dietary Amino Acid Deficiency Does Not Require GCN2.

Authors:  David E Leib; Zachary A Knight
Journal:  Cell Rep       Date:  2016-08-23       Impact factor: 9.423

Review 5.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

6.  Brainstem nutrient sensing in the nucleus of the solitary tract inhibits feeding.

Authors:  Clemence Blouet; Gary J Schwartz
Journal:  Cell Metab       Date:  2012-11-07       Impact factor: 27.287

7.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

Review 8.  Neuropeptide Y and energy balance: one way ahead for the treatment of obesity?

Authors:  S Dryden; H Frankish; Q Wang; G Williams
Journal:  Eur J Clin Invest       Date:  1994-05       Impact factor: 4.686

Review 9.  Amino acid homeostasis and signalling in mammalian cells and organisms.

Authors:  Stefan Bröer; Angelika Bröer
Journal:  Biochem J       Date:  2017-05-25       Impact factor: 3.857

10.  FGF21 regulates metabolism and circadian behavior by acting on the nervous system.

Authors:  Angie L Bookout; Marleen H M de Groot; Bryn M Owen; Syann Lee; Laurent Gautron; Heather L Lawrence; Xunshan Ding; Joel K Elmquist; Joseph S Takahashi; David J Mangelsdorf; Steven A Kliewer
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

View more
  11 in total

1.  Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.

Authors:  Kota Yano; Kanji Yamaguchi; Yuya Seko; Shinya Okishio; Hiroshi Ishiba; Nozomi Tochiki; Aya Takahashi; Seita Kataoka; Keiichiroh Okuda; Yu Liu; Hideki Fujii; Atsushi Umemura; Michihisa Moriguchi; Takeshi Okanoue; Yoshito Itoh
Journal:  Lab Invest       Date:  2021-11-03       Impact factor: 5.662

2.  High-protein and low-calorie diets improved the anti-aging Klotho protein in the rats' brain: the toxic role of high-fat diet.

Authors:  Anahid Shafie; Ahmad Mustafa Rahimi; Iraj Ahmadi; Fatemeh Nabavizadeh; Mina Ranjbaran; Ghorbangol Ashabi
Journal:  Nutr Metab (Lond)       Date:  2020-10-15       Impact factor: 4.169

3.  FGF21 Signals Protein Status to the Brain and Adaptively Regulates Food Choice and Metabolism.

Authors:  Cristal M Hill; Thomas Laeger; Madeleine Dehner; Diana C Albarado; Blaise Clarke; Desiree Wanders; Susan J Burke; J Jason Collier; Emily Qualls-Creekmore; Samantha M Solon-Biet; Stephen J Simpson; Hans-Rudolf Berthoud; Heike Münzberg; Christopher D Morrison
Journal:  Cell Rep       Date:  2019-06-04       Impact factor: 9.423

Review 4.  FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.

Authors:  Emma Henriksson; Birgitte Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

Review 5.  Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior.

Authors:  Chih-Ting Wu; Aki T Chaffin; Karen K Ryan
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.964

Review 6.  Protein Appetite at the Interface between Nutrient Sensing and Physiological Homeostasis.

Authors:  Md Shahjalal Khan; Redin A Spann; Heike Münzberg; Sangho Yu; Vance L Albaugh; Yanlin He; Hans-Rudolf Berthoud; Christopher D Morrison
Journal:  Nutrients       Date:  2021-11-16       Impact factor: 5.717

7.  FGF21 prevents low-protein diet-induced renal inflammation in aged mice.

Authors:  Han Fang; Sujoy Ghosh; Landon C Sims; Kirsten P Stone; Cristal M Hill; Denisha Spires; Daria V Ilatovskaya; Christopher D Morrison; Thomas W Gettys; Krisztian Stadler
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21

Review 8.  FGF21 and the Physiological Regulation of Macronutrient Preference.

Authors:  Cristal M Hill; Emily Qualls-Creekmore; Hans-Rudolf Berthoud; Paul Soto; Sangho Yu; David H McDougal; Heike Münzberg; Christopher D Morrison
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

9.  FGF21 signaling in glutamatergic neurons is required for weight loss associated with dietary protein dilution.

Authors:  Kyle H Flippo; Sharon O Jensen-Cody; Kristin E Claflin; Matthew J Potthoff
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.996

Review 10.  The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model.

Authors:  Redin A Spann; Christopher D Morrison; Laura J den Hartigh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.